Clinical Trial Update: Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports evaluation of subcutaneous ivermectin with or without zinc in COVID-19 patients across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Ivermectin (subcutaneous) (ivermectin)
• ZINC (Zinc chloride)

Snippet

Sponsor: Sohaib Ashraf | Conditions: Coronavirus Infection, COVID | Phase 1, Phase 2 | Status: UNKNOWN